GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $358,000 | +55.7% | 8,214 | +55.7% | 0.01% | +85.7% |
| Q1 2022 | $230,000 | -1.3% | 5,274 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $233,000 | +15.3% | 5,274 | 0.0% | 0.01% | +16.7% |
| Q3 2021 | $202,000 | -3.8% | 5,274 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $210,000 | -65.9% | 5,274 | -69.4% | 0.01% | -40.0% |
| Q1 2021 | $616,000 | -49.9% | 17,248 | -48.4% | 0.01% | -75.6% |
| Q4 2020 | $1,230,000 | -42.5% | 33,429 | -41.2% | 0.04% | +5.1% |
| Q3 2020 | $2,138,000 | -73.3% | 56,819 | -71.0% | 0.04% | -76.4% |
| Q2 2020 | $8,002,000 | -15.4% | 196,180 | -21.4% | 0.16% | -29.8% |
| Q1 2020 | $9,460,000 | +60.0% | 249,650 | +98.4% | 0.24% | -3.3% |
| Q4 2019 | $5,913,000 | -83.0% | 125,825 | -84.5% | 0.24% | -83.5% |
| Q3 2019 | $34,730,000 | +12.3% | 813,735 | +5.3% | 1.48% | +11.0% |
| Q2 2019 | $30,926,000 | +5.0% | 772,765 | +9.6% | 1.33% | +2.0% |
| Q1 2019 | $29,466,000 | +62.5% | 705,090 | +48.5% | 1.30% | +42.8% |
| Q4 2018 | $18,138,000 | +3415.1% | 474,690 | +3597.0% | 0.91% | +3869.6% |
| Q3 2018 | $516,000 | -5.0% | 12,840 | -4.7% | 0.02% | -8.0% |
| Q2 2018 | $543,000 | +3.8% | 13,476 | +0.6% | 0.02% | +4.2% |
| Q1 2018 | $523,000 | +10.1% | 13,390 | 0.0% | 0.02% | +14.3% |
| Q4 2017 | $475,000 | -39.9% | 13,390 | -31.3% | 0.02% | -43.2% |
| Q3 2017 | $791,000 | -5.3% | 19,483 | +0.6% | 0.04% | -9.8% |
| Q2 2017 | $835,000 | +10.3% | 19,358 | +7.8% | 0.04% | +7.9% |
| Q1 2017 | $757,000 | +29.8% | 17,958 | +18.6% | 0.04% | +22.6% |
| Q4 2016 | $583,000 | -7.6% | 15,138 | +3.4% | 0.03% | -6.1% |
| Q3 2016 | $631,000 | +9.4% | 14,638 | +10.0% | 0.03% | +6.5% |
| Q2 2016 | $577,000 | +15.2% | 13,305 | +7.8% | 0.03% | +10.7% |
| Q1 2016 | $501,000 | -10.7% | 12,345 | -11.3% | 0.03% | -9.7% |
| Q4 2015 | $561,000 | +6.9% | 13,910 | +1.8% | 0.03% | +3.3% |
| Q3 2015 | $525,000 | -11.6% | 13,660 | -4.2% | 0.03% | 0.0% |
| Q2 2015 | $594,000 | -18.4% | 14,265 | -9.6% | 0.03% | -14.3% |
| Q1 2015 | $728,000 | +6.6% | 15,780 | -1.3% | 0.04% | +6.1% |
| Q4 2014 | $683,000 | -12.0% | 15,980 | -5.4% | 0.03% | -13.2% |
| Q3 2014 | $776,000 | -3.0% | 16,890 | +13.0% | 0.04% | +2.7% |
| Q2 2014 | $800,000 | +9.1% | 14,950 | +9.0% | 0.04% | +5.7% |
| Q1 2014 | $733,000 | -95.1% | 13,720 | -95.1% | 0.04% | -95.2% |
| Q4 2013 | $15,006,000 | -11.4% | 281,070 | -16.7% | 0.73% | -15.6% |
| Q3 2013 | $16,929,000 | +1.7% | 337,435 | +1.3% | 0.86% | -2.9% |
| Q2 2013 | $16,641,000 | – | 333,025 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |